Insmed (INSM) Other financing activities (2014 - 2024)
Insmed (INSM) recorded quarterly Other financing activities of $3.7 million in Q4 2024, up 1013.69% quarter-over-quarter from -$409000.0 in Q2 2024.
Insmed (INSM) Other financing activities (2014 - 2024) Analysis & Trends
Insmed's Other financing activities history runs 8 years deep, the most recent figure standing at $3.7 million for Q4 2024.
- In Q4 2024, Other financing activities changed N/A year-over-year to $3.7 million; the TTM figure through Mar 2025 stood at $3.3 million (up 713.69% YoY), while the FY2024 annual figure was $3.7 million, up 206.81% from the prior year.
- Other financing activities was $3.7 million for Q4 2024 at Insmed, up from -$409000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $17.8 million in Q4 2022 to a low of -$936000.0 in Q4 2020.
- Historically, Other financing activities has averaged $2.7 million across 5 years, with a median of $212500.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Other financing activities surged 111043.75% in 2022, then tumbled 66.42% in 2024.
- A 5-year view of Other financing activities shows it stood at -$936000.0 in 2020, then jumped by 101.71% to $16000.0 in 2021, then soared by 111043.75% to $17.8 million in 2022, then tumbled by 93.15% to $1.2 million in 2023, then jumped by 206.81% to $3.7 million in 2024.
- The last three Other financing activities figures came in at $3.7 million (Q4 2024), -$409000.0 (Q2 2024), and $409000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.74 Mn |
| Dec 31, 2024 | 3.74 Mn |
| Jun 30, 2024 | -409,000.00 |
| Jun 30, 2024 | -409,000.00 |
| Mar 31, 2024 | 409,000.00 |
| Mar 31, 2024 | 409,000.00 |
| Mar 31, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | 17.78 Mn |
| Dec 31, 2022 | 17.78 Mn |
| Dec 31, 2021 | 16,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | -311,000.00 |
| Sep 30, 2021 | -311,000.00 |
| Dec 31, 2020 | -936,000.00 |
| Dec 31, 2020 | -936,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Jun 30, 2018 | 94,000.00 |
| Jun 30, 2018 | 94,000.00 |